Haematologica (Nov 2024)
FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies
- Pierre Peterlin,
- Joëlle Gaschet,
- Pascal Turlure,
- Marie-Pierre Gourin,
- Pierre-Yves Dumas,
- Sylvain Thepot,
- Ana Berceanu,
- Sophie Park,
- Marie-Anne Hospital,
- Thomas Cluzeau,
- Jose-Miguel Torregrosa-Diaz,
- Louis Drevon,
- Rosa Sapena,
- Fatiha Chermat,
- Lionel Ades,
- Sophie Dimicoli-Salazar,
- Maxime Jullien,
- Pierre Fenaux,
- Patrice Chevallier.
Affiliations
- Pierre Peterlin
- Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université – Angers University, Nantes
- Joëlle Gaschet
- CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université – Angers University, Nantes
- Pascal Turlure
- Clinical Hematology, Limoges University Hospital, Limoges
- Marie-Pierre Gourin
- Clinical Hematology, Limoges University Hospital, Limoges
- Pierre-Yves Dumas
- Clinical Hematology, Bordeaux University Hospital Haut-Lévêque, Pessac
- Sylvain Thepot
- Clinical Hematology, Angers University Hospital, Angers
- Ana Berceanu
- Clinical Hematology, Besançon University Hospital, Besançon
- Sophie Park
- Clinical Hematology, Grenoble University Hospital, Grenoble
- Marie-Anne Hospital
- Clinical Hematology, Institut Paoli Calmettes, Marseille
- Thomas Cluzeau
- Clinical Hematology, Nice University Hospital, Nice
- Jose-Miguel Torregrosa-Diaz
- Clinical Hematology, Poitiers University Hospital, Poitiers
- Louis Drevon
- Clinical Hematology, Saint Louis Hospital, Paris
- Rosa Sapena
- Groupe Francophone des Myélodysplasies, Paris
- Fatiha Chermat
- Groupe Francophone des Myélodysplasies, Paris
- Lionel Ades
- Clinical Hematology, Saint Louis Hospital, Paris
- Sophie Dimicoli-Salazar
- Clinical Hematology, Bordeaux University Hospital Haut-Lévêque, Pessac
- Maxime Jullien
- Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université – Angers University, Nantes
- Pierre Fenaux
- Groupe Francophone des Myélodysplasies, Paris
- Patrice Chevallier.
- Clinical Hematology, Nantes University Hospital, Nantes, France; CRCI2NA UMR INSERM 1307CNRS 6075 - Nantes Université – Angers University, Nantes
- DOI
- https://doi.org/10.3324/haematol.2024.286025
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
